Stability Study of 0.5 g/mL Urea Oral Solution in InOrpha®
Urea is recommended in the 2nd line treatment in moderate to severe hyponatraemia induced by syndrome of inappropriate antidiuretic hormone secretion (SIADH), when water restriction is insufficient. A posology of 0.25-0.5 g/kg daily is suggested. A usual but inadequate urea oral preparation, i. e. 1...
Wedi'i Gadw mewn:
Prif Awduron: | Bourbon Johan (Awdur), Dory Anne (Awdur), Perello Laurent (Awdur), Belotti Laure (Awdur), Reisz Fanny (Awdur), Ubeaud-Sequier Genevieve (Awdur), Gourieux Bénédicte (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
De Gruyter,
2019-08-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Stability of refrigerated miglustat after preparation in InOrpha® flavored suspending excipient for compounding of oral solutions and suspensions
gan: Riahi S, et al.
Cyhoeddwyd: (2015) -
Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL)
gan: Almasi Jannik, et al.
Cyhoeddwyd: (2023) -
0.5% hyperbaric bupivacaine - Do we still need a 4 ml ampoule?
gan: Rakhee Goyal, et al.
Cyhoeddwyd: (2012) -
Ramosetron 3.0 μg/mL Combining with Dexamethasone (0.05, 0.1, 0.2 mg/mL) in Infusion Solutions: A Physicochemical Stability Study
gan: Baoxia Fang, et al.
Cyhoeddwyd: (2024) -
Ropivacaine 0.025% mixed with fentanyl 3.0 μg/ml and epinephrine 0.5 μg/ml is effective for epidural patient-controlled analgesia after cesarean section
gan: Shaul Cohen, et al.
Cyhoeddwyd: (2015)